Sanofi

Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Sanofi
diabetes
ADA
Soliqua
clinical trials
Flag link:
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Will The Introduction Of A Third Potent Cholesterol Lowering Drug Expand or Shrink The Market?
Forbes
The Medicines Company
Amgen
Sanofi
Regeneron
inclisiran
PCSK9 inhibitors
Flag link:
Sanofi's Leadership Transition: What You Need To Know
Sanofi's Leadership Transition: What You Need To Know
Yahoo/Benzinga
Sanofi
Pharma CEOs
Paul Hudson
Olivier Brandicourt
Flag link:
A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report
A struggling Sanofi is preparing to hire Novartis senior pharma exec Paul Hudson as new CEO, replacing Brandicourt -- report
Endpoints
Sanofi
Pharma CEOs
Novartis
Paul Hudson
Olivier Brandicourt
Flag link:
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Fierce Pharma
China
Sanofi
Eli Lilly
Bristol-Myers Squibb
Flag link:
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
#ASCO19: Sanofi sets the stage for a late arrival of their multiple myeloma drug isatuximab — with J&J and Genmab laying in wait
Endpoints
Sanofi
Multiple Myeloma
isatuximab
ASCO 2019
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Go or no go? Merck, Regeneron and Alexion await US expansion
Go or no go? Merck, Regeneron and Alexion await US expansion
EP Vantage
Merck
Keytruda
Sanofi
Regeneron
Dupixent
Alexion
Soliris
FDA
Dova Pharmaceuticals
Retrophin
Flag link:
Verily lures major pharmas with promise of speedier clinical research
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Verily
Alphabet
clinical trials
Pfizer
Novartis
Sanofi
Otsuka
Flag link:
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Sanofi Joins Drugmakers' Bid to Treat Patients With Software
Yahoo/Bloomberg
Sanofi
digital pharma
Happify Health
digital therapeutics
depression
multiple sclerosis
Flag link:
Vendu! Weeks after Sanofi cuts ties to Alnylam, the pharma giant offloads $842M of its stock
Vendu! Weeks after Sanofi cuts ties to Alnylam, the pharma giant offloads $842M of its stock
Endpoints
Sanofi
Alnylam
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Flag link:
Praluent's lower list price isn't yielding better sales yet
Praluent's lower list price isn't yielding better sales yet
Biopharma Dive
Sanofi
Regeneron
Praluent
drug pricing
Flag link:
U.S. FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
U.S. FDA approves expanded label for Regeneron/Sanofi's cholesterol drug
Yahoo/Reuters
Regeneron
Sanofi
Praluent
MACE
FDA
Flag link:
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Fierce Pharma
Sanofi
Bioverativ
M&A
diabetes
Eloctate
Roche
Hemlibra
Flag link:
Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales
Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales
Yahoo/Zacks.com
Sanofi
earnings
Flag link:
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit
Fierce Pharma
Sanofi
Bluebird Bio
Kendall Square
Boston
Flag link:
Before House hearing, Sanofi cuts insulin prices for some patients
Before House hearing, Sanofi cuts insulin prices for some patients
Stat
Sanofi
insulin
diabetes
drug pricing
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
Sanofi plans sales layoffs—again—in primary care, diabetes
Sanofi plans sales layoffs—again—in primary care, diabetes
Fierce Pharma
Sanofi
layoffs
primary care
diabetes
drug reps
Flag link:

Pages